PubMed Health⌕ Search

PubMed · 15309556

Strategies to influence PVR development.

Abstract

Proliferative vitreo-retinopathy (PVR) is a complication of rhegmatogenous retinal detachment or severe ocular trauma (intraocular foreign body, penetration, perforation, contusion, rupture). The risk of PVR varies from 10 to 40% depending on the original disease. Strategies to influence the risk of PVR include surgical techniques, pharmacological adjuncts, and preventive measurements. Surgical influences on the risk of PVR comprise: surgical skills (buckling, atraumatic procedure), primary vitrectomy, early vitrectomy, retinectomy, choice of vitreous tamponade agent. The influence of most such parameters is not confirmed by prospective randomized studies. Pharmaceutical adjuncts include daunomycin, 5-fluoruracil plus heparin and others. The influence of most such parameters has been studied by prospective randomized studies. The effect is statistically significant, its clinical relevance is subject of current discussion. Prevention of PVR, via prevention of injury, was successful in the past as shown by the reduction of wind screen injuries after the seatbelt legislation was installed, and reduction of work related injuries from protective eyewear. As for the treatment of existent PVR despite some progress in the past, there should be better ways of treatment ahead of us.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bernd Kirchhof. 2004-08-10. Strategies to influence PVR development.. https://doi.org/10.1007/s00417-004-0978-8

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Safe fertility-preserving management in gynecological malignancies.

OBJECTIVE: To provide a review in the available literature about the safe fertility-preserving management in gynecological malignancies, focusing on the selection criteria of the patients, treatment options and follow-up. DESIGN: Literature survey. RESULTS: The incidence of cancer in women who still want to get pregnant is increasing significantly. An early detection in gynecological malignancies allows less aggressive approaches to cure such disorders. A more conservative management, which preserves fertility, is considered safe and an option for those who have not completed their child-bearing. CONCLUSIONS: Selected patients with cervical, endometrial and ovarian cancer may be candidates to a safe fertility-preserving management. A careful stage and follow-up of the patients is essential to achieve success with this practice.

Chemotherapy, Adjuvant↗

Defining optimal therapy for muscle invasive bladder cancer.

PURPOSE: We defined an optimal curative strategy for muscle invasive bladder cancer and to determine how best to deliver curative therapy. MATERIALS AND METHODS: We reviewed published reports from 1985 to 2006 dealing with the treatment of muscle invasive (stage T2-T4a) bladder cancer. We analyzed all cohort, phase II and randomized phase III studies providing level 1 to 3 evidence impacting survival. RESULTS: Cisplatin based chemotherapy combined with high quality radical cystectomy and complete pelvic lymph node dissection improves survival over that of cystectomy alone. Surgery quality is an important predictor of survival even in patients receiving chemotherapy. Neoadjuvant chemotherapy is favored over adjuvant chemotherapy because it is better tolerated and more patients are able to receive effective therapy before rather than after surgery. CONCLUSIONS: Neoadjuvant chemotherapy followed by radical cystectomy and complete pelvic lymph node dissection is the optimal curative strategy in most patients presenting with muscle invasive bladder cancer.

Chemotherapy, Adjuvant↗